Ticker Symbol: IMNM
Immunome Inc
$17.94 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001472012
Company Profile
immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. this proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. we then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: immunomeinc.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:30 PM EST
Previous Close: $7.95
Change:
-$0.25
(
-3.05%)
Days Range: $7.66 - $8.23
Beta: -
52wk. High: $9.52
52wk. Low: $2.20
Ytd. Change 267.99%
50 Day Moving Average: $7.65
200 Day Moving Average: $6.60
Shares Outstanding: 42729097
Valuation
Market Cap: 9.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A